From 2013 to 2017, tuberculosis treatment coverage in China remained relatively stable around 88-89 units. The coverage improved slightly to 92 units in 2018 but then saw a decline to 75 units in 2020 and 2021. There was a sharper drop to 67 units in 2022, continuing to 62 units in 2023. Forecast data predicts a continued decline, with coverage expected to decrease to 50 units by 2028. The forecasted 5-year compound annual growth rate (CAGR) is -3.26%, and the overall 5-year growth rate is -15.25%. In 2023, the unit stood at 62.
Future trends to watch for include advancements in medical technology, public health policy changes, and the impact of international health initiatives on tuberculosis treatment accessibility and coverage. Additionally, increasing awareness and funding for TB treatment programs could influence future trends positively.
